Catalyst Wire Dossier Catalyst Wire Dossier

Levulan PDT

5-aminolevulinic acid (5-ALA) photodynamic therapy · DUSA Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Levulan PDT, covering 2013-02-04 to 2013-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK) [Phase 2]

See pricing